Kalvista Pharmaceuticals earnings were N/A for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest KALV earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KALV reported annual earnings of N/A, with N/A growth.
KALV earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
KALV Return on Equity
Current Company
N/A
Current Industry
-31.4%
Current Market
28.9%
KALV Return on Assets
Current Company
N/A
Current Industry
-9.6%
Be the first to know when KALV announces earnings.
Kalvista Pharmaceuticals Earnings Reports & History FAQ
What were Kalvista Pharmaceuticals's earnings last quarter?
On KALV's earnings call on Invalid Date, Kalvista Pharmaceuticals (NASDAQ: KALV) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total KALV earnings for the quarter were N/A. In the same quarter last year, Kalvista Pharmaceuticals's earnings per share (EPS) was N/A.
Is Kalvista Pharmaceuticals profitable or losing money?
As of the last Kalvista Pharmaceuticals earnings report, Kalvista Pharmaceuticals is currently losing money. Kalvista Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2025 was N/A, a N/A decrease year over year.
What was KALV's earnings growth in the past year?
As of Kalvista Pharmaceuticals's earnings date in Invalid Date, Kalvista Pharmaceuticals's earnings has grown year over year. KALV earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.